D.G. Downey

1. Safety and antimicrobial efficacy of CSL787, a novel nebulized IgG therapy, in patients with bronchiectasis: results from a randomized phase 1 trial
   2026/04/07 by D.G. Downey, Ilka Schulze, Andreas Eich +6 · 1 voice
   Medicine · #Asthma and respiratory diseases #Cystic Fibrosis Research Advances #Respiratory and Cough-Related Research